Investment Rationale · HPA
Investment thesis
NOCD will use the funding to expand its therapist network, shift public perception of OCD, and strengthen analytics for health payers.
With this new round of funding, NOCD will expand their OCD-specialty therapist network, further redefine the public perception of OCD, and enhance NOCD’s leading analytics and outcomes capabilities with payers seeking to provide their OCD population with more robust offerings.
Why the firm invested
HPA Deal Lead Chris Henger assisted NOCD in defining customer segments to drive teletherapy product conversion.
Notably, Chris helped NOCD build its customer segments, driving conversion for its teletherapy product. His support of NOCD is complemented by HPA Member Dipa Mehta who has expertise in the behavioral health industry and HPA Member Ann Deters
Traction
NOCD delivers more than 250,000 therapy sessions annually.
delivers more than 250,000 therapy sessions each year
NOCD achieves an average 35% reduction in OCD symptom severity for patients.
and drives on average a 35% reduction in OCD symptom severity.
Business model
Community-Driven Therapy provides a scalable and effective model to identify, engage, and manage individuals with OCD.
NOCD’s success demonstrates the scalability and efficacy of Community-Driven Therapy, a model that better identifies, engages and manages people with OCD.
What founders can learn
- What actually moved the decision: HPA wrote that HPA Deal Lead Chris Henger assisted NOCD in defining customer segments to drive teletherapy product conversion.
- The traction evidence that carried weight: HPA wrote that NOCD delivers more than 250,000 therapy sessions annually.
- How the model was assessed: HPA wrote that Community-Driven Therapy provides a scalable and effective model to identify, engage, and manage individuals with OCD.
Source and provenance
Investment Rationale published by HPA on hpa.vc (first-party source). Read the original
